Zuletzt aktualisiert: August 16, 2026
Stammzelltherapie bei Alopezie, Haarausfall.
Forscher haben eine neue Möglichkeit entdeckt, die Menge und Qualität der Stammzellen in den Haarfollikeln zu aktivieren und zu erhöhen, um das Haarwachstum anzukurbeln.
Es fördert das Haarwachstum bei Menschen mit Haarausfall oder Alopezie, which is hair loss associated with such factors as hormonal imbalance, Stress, aging or chemotherapy treatment.
Hair restoration remains a specific and largely investigational area. For an overview of cellular products, Sicherheit, FDA regulation and other research applications, see our guide to stem-cell-based therapies .
Hair follicle stem cells are long-lived cells in the hair follicle; they are present in the skin and produce hair throughout a person’s lifetime. Sie sind “quiescent,” meaning they are normally inactive, but they quickly activate during a new hair cycle, which is when new hair growth occurs. The quiescence of hair follicle stem cells is regulated by many factors. In certain cases they fail to activate, which is what causes hair loss.
Adding more stem cells by using local injections would activate the cells and grow hair more quickly.
Stimulation of hair growth through hair follicle stem cells is very promising given how many millions of people, both men and women, deal with hair loss. ICH
When talking about hair transplant therapies, Stammzelltherapie is one such process considered for hair loss. This treatment is very efficient. It is a non-surgical therapy to stimulate and regrow hair follicles. Stem cells that are present in the middle of the follicle ensure the continuous supply of cells.
Verfahren (sample) :
Human stem cells therapy protocol and injections.
For each patient, the scalp affected by hair loss was divided into four areas (frontal, parietal, vertex, and occipital); local anesthesia was injected in the treated areas. Interfollicular SCs injections (0.2 mL·cm2) were administered to select areas of the scalp at a depth of 5 mm.
In patients with hair loss localized to the frontal and parietal regions, SCs injections were delivered exclusively to the frontal scalp
For patients with hair loss limited to the parietal and vertex regions, HSCs was injected in the parietal region
Geduldig (sample):
A smoker 45-year-old male patient affected by androgenetic alopecia classified AGA 3 according to Nordwood-Hamilton scale.
Clinical results
In Summe, 23 weeks after the last treatment with HSCs mean hair count and hair density increases over baseline values . Insbesondere, a 29%±5% increase in hair density for the treated area .
In this preliminary report, we showed the clinical effect of the injections of stem cells into the scalp tissue.
Stem cells can improve the formation of new follicles.
Einzelheiten – https://nbscience.com/nbs-stem-cells-clinic/
Wissenschaftliche Fallbesprechung
Möchten Sie verstehen, ob aktuelle klinische Programme, aktuelle Forschungsentwicklungen, oder neue Ansätze können sein relevant für Ihre individuelle Situation?
Senden Sie Ihre Frage an unser wissenschaftliches Team. Der Hauptsitz von NBScience im Vereinigten Königreich koordiniert Anfragen im internationalen Netzwerk medizinischer Zentren, Wissenschaftler, und spezialisierte Berater.
- Überprüfung der von Ihnen bereitgestellten Informationen
- Relevante Informationen zu Forschung und klinischen Programmen
- Eine klare Antwort, die sich auf Ihre Situation konzentriert
Keine Verpflichtung. Ihre Frage wird vertraulich behandelt.
Nur Bildungs- und Forschungsinformationen. Dieser Dienst funktioniert nicht stellen eine medizinische Beratung dar, Diagnose, Rezept, oder eine personalisierte Behandlungsempfehlung.
